GCVI Summit 2018
Skip Content

17 February 2017

Xcell extends funding by $12m

The Illumina-backed cellular technology developer has closed $12m in a series A round led by HBM Genomics.

Author: Robert Lavine, News Editor

Xcell Biosciences, a US-based cell culturing platform developer backed by gene editing company Illumina, completed a $12m series A round led by HBM Genomics yesterday.